Arcadia, a leading data analytics platform for healthcare and life sciences, and Datavant, a leader in helping organizations securely connect health data, announced a partnership to enable de-identified connectivity of Arcadia’s electronic health record data for life sciences research and commercial analytics.
This free-to-attend event features tangible takeaways and tailored sessions to maximize e-prescribing and EHR technology engagement for optimal communication. Plus, benefit from Q&As with the speakers following the session.
For more than 50 years, randomized controlled trials (RCTs) have been used by the biopharmaceutical industry and regulators to evaluate the efficacy and safety of new medications as well as medical products that are being repurposed for new uses. But regulators and biopharmaceutical companies are being pushed to modernize their approaches to expedite drug development, which has resulted in increased attention to potential contributions of real world evidence (RWE).
ObvioHealth Raises $31 Million, Adds Two Strategic Partners to Bolster Capabilities and Drive Growth Globally NEW YORK, July 1, 2021 /PRNewswire/ — ObvioHealth, a global Virtual Research Organization (VRO), announces it […]
New Research Sheds Light on the Temporary Loss of Smell Stemming from Covid-19
ACE2 (angiotensin-converting enzyme-2), Clinical Trials, Coronavirus Disease 2019 (COVID-19), Electronic Health Records, Harvard Medical School, JAMA Otolaryngology Head and Neck Surgery, Medical Schools, Neuroscience, Olfactory Neurons, Proteins, R&D, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Smell, Symptoms: Coronavirus Disease 2019 (COVID-19), TasteAccording to a study published in the journal Science Advances, an international team of researchers led by neuroscientists at Harvard Medical School uncovered which olfactory cell types are most vulnerable to infection by SARS-CoV-2, which causes Covid-19.
How NPP Is Changing With the Onset of COVID-19
Artificial Intelligence, At-Home Testing, Behavioral Changes, Conferences, Coronavirus Disease (COVID-19) Pandemic, Digital, Doctors, Electronic Health Records, HCPs, Health Insurance, Healthcare Communications Agencies, Marketing & Advertising, Physicians, Sales Forces, Sales Reps, Social Media, Telemedicine, Trends, VeevaGreater Than One’s Christa Toole analyzes how healthcare marketers are adjusting to the current health crisis in a variety of ways.
Industry contributors shared with Med Ad News topics that will have a major impact on pharma marketing during 2020.
U.S. Presidential candidate Elizabeth Warren along with fellow Senators Richard Blumenthal and Bill Cassidy wrote a letter to Alphabet’s Google to raise questions about the company’s access to the health records of tens of millions of Americans.
EVERSANA and OptimizeRx Corp. announced their partnership to modernize the patient experience and improve health outcomes by combining a real-time electronic health records (EHR) network with customized, wraparound patient support services.
Consumer/Patient Experience Special Feature: Masters Of The Pharma Universe: 4 Databases Every Digital Marketer Must Know
Analytics, Audience Identity Data, Big Data, Brands, Business, Consumer/Patient Experience, Data, Drug Distribution, Electronic Health Records, Electronic Medical Records (EMR), Issue Archives, June 2018Nearly two-thirds of U.S. senior business decision-makers rank big data/analytics first among the technologies necessary for enhancing the customer experience. A similar number put “improving data analysis capabilities” at the top of their priorities.